Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Hans Gelderblom; Vivek A. Bhadri; Silvia Stacchiotti; Sebastian Bauer; Andrew J. Wagner; Michiel A. J. van de Sande; Nicholas M. Bernthal; Antonio López–Pousa; Albiruni Abdul Razak; Antoîne Italiano; Mahbubl Ahmed; Axel Le Cesne; Gabriel Tinoco; Kjetil Boye; Javier Martín‐Broto; Emanuela Palmerini; Salvatore Tafuto; Sarah Pratap; Benjamin Powers; Peter Reichardt; Antonio Casado; Piotr Rutkowski; Christopher Tait; Fiona Zarins; B. Harrow; Maitreyi G. Sharma; Rodrigo Ruiz‐Soto; Matthew L. Sherman; Jean Yves Blay; William D. Tap; Herbert H. Loong; Antonella Brunello; Andreas H. Krieg; Mark Algulnik; Richard F. Riedel; Scott H. Okuno; Elizabeth T. Loggers; Thierry Alcindor; Virginia Ferraresi; César Serrano; R. Lor Randall; Breelyn A. Wilky; Vinod Ravi

doi:10.1016/s0140-6736(24)00885-7

Related publications

Article2018

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Michele Maio, Karl D. Lewis, Lev Demidov, Mario Mandalà, Igor Bondarenko, Paolo A. Ascierto, Christopher Herbert, Andrzej Maćkiewicz, Piotr Rutkowski, Alexander Guminski, Grant R. Goodman, Brian Simmons, Chenglin Ye, Yibing Yan, Dirk Schadendorf, Gabriela Cinat, Luis Fein, Michael P. Brown, Alexander Guminski, Andrew Haydon, Adnan Khattak, Catriona M. McNeil, Phillip Parente, Jeremy Power, Rachel Roberts‐Thomson, Shahneen Sandhu, Craig Underhill, Suresh Varma, Thomas G. Berger, Ahmad Awada, Nathalie Blockx, Véronique Buyse, Jeroen Mebis, Fábio Franke, Sérgio Jobim Azevedo, Nicolas Lazaretti, Rahima Jamal, Catalin Mihalcioiu, Teresa M. Petrella, Kerry J. Savage, Xinni Song, Ralph Wong, Nina Dabelić, Stjepko Pleština, Željko Vojnović, Petr Arenberger, Ivo Kocák, Ivana Krajsová, Eugen Kubala, Bohuslav Melichar, Yvetta Vantuchová, Kadri Putnik, Brigitte Dréno, Caroline Dutriaux, Jean‐Jacques Grob, P. Joly, J.‐P. Lacour, Nicolás Meyer, Laurent Mortier, L. Thomas, Michael Fluck, Thilo Gambichler, Jessica C. Hassel, Axel Hauschild, Dirk Schadendorf, Paul Donnellan, John McCaffrey, Derek G. Power, Samuel Ariad, Gil Bar‐Sela, Daniel Hendler, Ilan G. Ron, Jacob Schachter, Paolo A. Ascierto, Alfredo Berruti, Luca Bianchi, Vanna Chiarion‐Sileni, Francesco Cognetti, Riccardo Danielli, Anna Maria Di Giacomo, Luca Gianni, Aron Goldhirsch, Michele Guida, Michele Maio, Mario Mandalà, Paolo Marchetti, Paola Queirolo, Armando Santoro, Ellen Kapiteijn, Andrzej Maćkiewicz, Piotr Rutkowski, P. Ferreira, Lev Demidov, Georgy Gafton, Yulia Makarova, Zoran Andrić, Nada Babović, Darjana Jovanovic, Lidija Kandolf Sekulović, Graham Cohen

Article2019

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

Mark T. Drayson, Stella Bowcock, Tim Planche, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Jill Wood, Kerry Raynes, Helen Higgins, Bryony Dawkins, David Meads, Claire Hulme, Irene M. Monahan, Kamaraj Karunanithi, Helen Dignum, Edward Belsham, Jeff Neilson, Beth Harrison, Anand Lokare, Gavin Campbell, Michael R Hamblin, Peter M. Hawkey, ,

Article2017

S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial

Masatoshi Kudo, Michihisa Moriguchi, Kazushi Numata, Hisashi Hidaka, Hironori Tanaka, Masafumi Ikeda, Seiji Kawazoe, Shinichi Ohkawa, Yozo Sato, Shuichi Kaneko, Junji Furuse, Madoka Takeuchi, Xuemin Fang, Yoshito Date, Masahiro Takeuchi, Takuji Okusaka

Article2018

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios A Dimopoulos, Francesca Gay, Fredrik Schjesvold, Meral Beksaç, Roman Hájek, Katja Weisel, Hartmut Goldschmidt, Vladimír Maisnar, Philippe Moreau, Chang Ki Min, Agnieszka Pluta, Wee Joo Chng, Martin Kaiser, Sonja Zweegman, María‐Victoria Mateos, Andrew Spencer, Shinsuke Iida, Gareth J. Morgan, Kaveri Suryanarayan, Zhaoyang Teng, Tomáš Skácel, Antonio Palumbo,

Article2022

1509P Efficacy and safety of vimseltinib in tenosynovial giant cell tumour (TGCT): Phase II expansion

Jean Yves Blay, H. Gelderblom, P. Rutkowski, A. Wagner, Meike van de Sande, A. Falcon Gonzalez, S. Stacchiotti, A. Le Cesne, T. Alcindor, C. Serrano, E. Palmerini, Vishnu Ravi, A. Casado Herráez, B. Seddon, Michael F. Vallee, R. Jarecha, M. Sharma, R. Ruiz-Soto, M.L. Sherman, W.D. Tap